HLA‐DP genes polymorphisms associate with hepatitis B surface antigen kinetics and seroclearance during nucleot(s)ide analogue therapy

Publisher： John Wiley & Sons Inc

E-ISSN： 1478-3231|35|4|1290-1302

ISSN： 1478-3223

Source： LIVER INTERNATIONAL (ELECTRONIC), Vol.35, Iss.4, 2015-04, pp. : 1290-1302

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

HLA‐DP, IL28B gene polymorphisms and IFN

By  

HEPATOLOGY RESEARCH, Vol. 44, Iss. 9, 2014-09 ,pp. : 1000-1007

John Wiley & Sons Inc

Access to resources Recommend Favorite

Systematic review: cessation of long‐term nucleos(t)ide analogue therapy in patients with hepatitis B e antigen‐negative chronic hepatitis B

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 3, 2015-08 ,pp. : 243-257

John Wiley & Sons Inc

Access to resources Recommend Favorite

Hepatitis B surface antigen levels after hepatitis B e‐antigen seroclearance: a longitudinal follow‐up study

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 3, 2015-03 ,pp. : 854-859

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long‐term safety and efficacy of nucleo(t)side analogue therapy in hepatitis B

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 38, Iss. S1, 2018-02 ,pp. : 84-89

John Wiley & Sons Inc

Access to resources Recommend Favorite

Reappearance of serum hepatitis B viral DNA in patients with hepatitis B surface antigen seroclearance

By  

HEPATOLOGY, Vol. 270-9139, Iss. 4, 2015-10 ,pp. : 1329-1329

John Wiley & Sons Inc

Access to resources Recommend Favorite